Alfalfa (Medicago sativa L.): A clinical decision support tool

Journal of Herbal Pharmacotherapy

Volumn 3, Issue 2, 2003, Pages 69-90

  Basch, Ethan ^d   Ulbricht, Catherine ^a   Harrison, Michelle ^d   Sollars, David ^d   Smith, Michael ^d   Dennehy, Cathi ^b   Szapary, Philippe ^c  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

2 BETA HYDROXY 3 BETA O (BETA GLUCOPYRANOSYL) DELTA 12 OLEANENE 23,28 DIONIC ACID; ALFALFA EXTRACT; ALPHA TOCOPHEROL; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ASCORBIC ACID; CAMPESTEROL; CANAVANINE; CHLOLESTAID; CHLORPROMAZINE; CYCLOARTENOL; GLUCOSE; HEDERAGENIN GLYCOSIDE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOCHOLESTEROLEMIC AGENT; IRON; LIVER ENZYME; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEDICAGENIC ACID; ORAL CONTRACEPTIVE AGENT; PLANT EXTRACT; RETINOL; SAPONIN; SITOSTEROL; SOYASAPOGENOL; STIGONOSTEROL; THYROID HORMONE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITAMIN K GROUP; WARFARIN;

ALFALFA; ANTIFUNGAL ACTIVITY; ARTHRITIS; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; DERMATITIS; DIET SUPPLEMENTATION; DRUG INDICATION; DRUG SAFETY; DRUG TOLERABILITY; FLATULENCE; FOOD DRUG INTERACTION; GASTROINTESTINAL SYMPTOM; GOUT; HERBAL MEDICINE; HUMAN; HYPOGLYCEMIA; HYPOKALEMIA; LUPUS VULGARIS; MEDICAL DECISION MAKING; MEDICAL LITERATURE; NONHUMAN; PANCYTOPENIA; PRIORITY JOURNAL; RHEUMATIC DISEASE; RISK BENEFIT ANALYSIS; SPLENOMEGALY;

EID: 0041695292     PISSN: 15228940     EISSN: None     Source Type: Journal    
DOI: 10.1300/J157v03n02_09     Document Type: Article

References (56)

1. Polk IJ. Alfalfa pill treatment of allergy may be hazardous. JAMA 1982; 247(10):1493.
2. Polacheck I, Zehavi U, Naim M, Levy M, Evron R. Activity of compound G2 isolated from alfalfa roots against medically important yeasts. Antimicrob Agents Chemother 1986: 30(2):290-294.
3. Jurzysta M, Waller GR. Antifungal and hemolytic activity of aerial parts of alfalfa (Medicago) species in relation to saponin composition. Adv Exp Med Biol 1996: 404:565-574.
4. Malinow MR, Bardana EJ, Jr., Pirofsky B, Craig S, McLaughlin P. Systemic lupus erythematosus-like syndrome in monkeys fed alfalfa sprouts: role of a non-protein amino acid. Science 1982; 216(4544):415-417.
5. Prete PE. The mechanism of action of L-canavanine in inducing autoimmune phenomena. Arthritis Rheum 1985; 28(10):1198-1200.
6. Roberts JL, Hayashi JA. Exacerbation of SLE associated with alfalfa ingestion. N Engl J Med 1983; 308(22):1361.
7. Herbert V, Kasdan TS. Alfalfa, vitamin E, and autoimmune disorders. Am J Clin Nutr 1994: 60(4):639-640.
8. Farnsworth NR. Alfalfa pills and autoimmune diseases. Am J Clin Nutr 1995; 62(5):1026-1028.
9. Malinow MR, Bardana EJ, Jr., Goodnight SH, Jr. Pancytopenia during ingestion of alfalfa seeds. Lancet 1981: 1(8220 Pt 1):615.
10. Molgaard J, von Schenck H, Olsson AG. Alfalfa seeds lower low density lipoprotein cholesterol and apolipoprotein B concentrations in patients with type II hyperlipoproteinemia. Atherosclerosis 1987; 65(1-2):173-179.
11. Malinow MR, McLaughlin P, Stafford C. Alfalfa seeds: effects on cholesterol metabolism. Experientia 1980; 36(5):562-564.
12. Malinow MR, McNulty WP, Houghton DC, Kessler S, Stenzel P, Goodnight SH, Jr. et al. Lack of toxicity of alfalfa saponins in cynomolgus macaques. J Med Primatol 1982; 11(2):106-118.
13. Malinow MR, Connor WE, McLaughlin P, Stafford C, Lin DS, Livingston AL et al. Cholesterol and bile acid balance in Macaca fascicularis. Effects of alfalfa saponins. J Clin Invest 1981: 67(1):156-162.
14. Grigorashvili GZ, Proidak NI. [Analysis of safety and nutritive value of protein isolated from alfalfa]. Vopr. Pitan. 1982; 5:33-37. Ref Type: Abstract.
15. Brandenburg DM. Alfalfa of the family Leguminosae. JAMA 1983; 249(24): 3303.
16. Kaufman W. Alfalfa seed dermatitis. JAMA 1954: 155(12):1058-1059.
17. Swanston-Flatt SK, Day C, Bailey CJ, Flatt PR. Traditional plant treatments for diabetes. Studies in normal and streptozotocin diabetic mice. Diabetologia 1990; 33(8):462-464.
18. Gray AM, Flatt PR. Pancreatic and extra-pancreatic effects of the traditional anti-diabetic plant, Medicago sativa (lucerne). Br J Nutr 1997: 78(2):325-334.
19. Rubenstein AH, Levin NW, Elliott GA. Manganese-induced hypoglycemia. Lancet 1962;1348-1351.
20. Shemesh M, Lindner HR, Ayalon N. Affinity of rabbit uterine oestradiol receptor for phyto-oestrogens and its use in a competitive protein-binding radioassay for plasma coumestrol. J Reprod Fertil 1972; 29(1):1-9.
21. Elakovich SD, Hampton JM. Analysis of coumestrol, a phytoestrogen, in alfalfa tablets sold for human consumption. J Agric Food Chem 1984; 32(1):173-175.
22. Kurzer MS, Xu X. Dietary phytoestrogens. Annu Rev Nutr 1997; 17:353-381.
23. Feingold RM. Should we fear "health foods"'? Arch Intern Med 1999; 159(13): 1502.
24. Jackson IM. Abundance of immunoreactive thyrotropin-releasing hormone-like material in the alfalfa plant. Endocrinology. 1991: 108(1): 344-346. Ref Type: Abstract.
25. Mohle-Boetani J, Werner B, Polumbo M, et al. From the Centers for Disease Control and Prevention. Alfalfa sprouts-Arizona, California, Colorado, and New Mexico, February-April, 2001. JAMA 2002; 287(5):581-582.
26. Backer HD, Mohle-Boetani JC, Werner SB, Abbott SL, Farrar J, Vugia DJ. High incidence of extra-intestinal infections in a Salmonella Havana outbreak associated with alfalfa sprouts. Public Health Rep 2000; 115(4):339-345.
27. Mahon BE, Ponka A, Hall WN, Komatsu K, Dietrich SE, Siitonen A. et al. An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis 1997; 175(4):876-882.
28. Ponka A, Andersson Y, Siitonen A, et al. Salmonella in alfalfa sprouts. Lancet 1995; 345:462-463.
29. Taormina PJ, Beuchat LR, Slutsker L. Infections associated with eating seed Sprouts: an international concern. Emerg Infect Dis 1999; 5(5):626-634.
30. Van Beneden CA, Keene WE, Strang RA, Werker DH, King AS, Mahon B. et al. Multinational outbreak of Salmonella enterica serotype Newport infections due to contaminated alfalfa sprouts. JAMA 1999; 281(2):158-162.
31. Farber JM, Carter AO, Varughese PV, Ashton FE, Ewan EP. Listeriosis traced to the consumption of alfalfa tablets and soft cheese. N Engl J Med 1990: 322(5):338.
32. Farnsworth NR, Bingel AS, Cordell GA, Crane FA, Fong HH. Potential value of plants as sources of new antifertility agents I. J Pharm Sci 1975; 64(4):535-598.
33. Yanaura S, Sakamoto M. Effect of alfalfa meal on experimental hyperlipidemia. Nippon Yakurigaku Zasshi. 1975: 71(5):387-393. Ref Type: Abstract.
34. Kritchevsky D, Story JA. Fiber, hypercholesteremia, and atherosclerosis. Lipids 1978; 13(5):366-369.
35. Mackler BP, Herbert V. The effect of raw wheat bran, alfalfa meal and alpha-cellulose on iron ascorbate chelate and ferric chloride in three binding solutions. Am J Clin Nutr 1985; 42(4):618-628.
36. Morimoto I. A study on immunological effects of L-canavanine. Kobe J Med Sci 1989; 35(5-6):287-298.
37. Hwang J, Hodis HN, Sevanian A. Soy and alfalfa phytoestrogen extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem 2001; 49(1):308-314.
38. Malinow MR, McLaughlin P, Stafford C, Livingston AL, Kohler GO, Cheeke PR. Comparative effects of alfalfa saponins and alfalfa fiber on cholesterol absorption in rats. Am J Clin Nutr 1979; 32(9):1810-1812.
39. Stochmal A, Piacente S, Pizza C, De Riccardis F, Leitz R, Oleszek W. Alfalfa (Medicago sativa L.) flavonoids. 1. Apigenin and luteolin glycosides from aerial parts. J Agric Food Chem 2001: 49(2):753-758.
40. Smith-Barbaro P, Hanson D, Reddy BS. Carcinogen binding to various types of dietary fiber. J Natl Cancer Inst 1981; 67(2):495-497.
41. Rosenthal GA. The biological effects and mode of action of L-canavanine, a structural analogue of L-arginine. Q Rev Biol 1977; 52(2):155-178.
42. Polacheck I, Zehavi U, Naim M, Levy M, Evron R. The susceptibility of Cryptococcus neoformans to an antimycotic agent (G2) from alfalfa. Zentralbl. Bakteriol. Mikrobiol. Hyg, [A] 1986; 261(4):481-486. Ref Type: Abstract.
43. Polacheck I, Levy M, Guizie M, Zehavi U, Naim M, Evron R. Mode of action of the antimycotic agent G2 isolated from alfalfa roots. Zentralbl Bakteriol 1991; 275(4): 504-512.
44. Malinow MR, McLaughlin P, Papworth L, Stafford C, Kohler GO, Livingston AL et al. Effect of alfalfa saponins on intestinal cholesterol absorption in rats. Am J Clin Nutr 1977; 30(12):2061-21067.
45. Malinow MR, McLaughlin P, Kohler GO, Livingston AL. Prevention of elevated cholesterolemia in monkeys. Steroids 1977; 29(1):105-110.
46. Srinivasan SR, Patton D, Radhakrishnamurthy B, Foster TA, Malinow MR, McLaughlin P, et al. Lipid changes in atherosclerotic aortas of Macaca fascicularis after various regression regimens. Atherosclerosis 1980; 37(4):591-601.
47. Cookson FB, Fedoroff S. Quantitative relationships between administered cholesterol and alfalfa required to prevent hypercholesterolaemia in rabbits. Br J Exp Pathol 1968; 49(4):348-355.
48. Barichello AW, Fedoroff S. Effect of ileal bypass and alfalfa on hypercholesterolaemia. Br J Exp Pathol 1971; 52(1):81-87.
49. Esper E, Barichello AW, Chan EK, Matts JP, Buchwald H. Synergistic lipid-lowering effects of alfalfa meal as an adjuvant to the partial ileal bypass operation. Surgery 1987; 102(1):39-51.
50. Malinow MR, McLaughlin P, Naito HK, Lewis LA, McNulty WP. Effect of alfalfa meal on shrinkage (regression) of atherosclerotic plaques during cholesterol feeding in monkeys. Atherosclerosis 1978; 30(1):27-43.
51. Malinow MR, McLaughlin P, Naito HK, et al. Regression of atherosclerosis during cholesterol feeding in Macaca fascicularis. Am J Cardiol. 1978; 41:396. Ref Type: Abstract.
52. Morimoto I, Shiozawa S, Tanaka Y, Fujita T. L-canavanine acts on suppressor-inducer T cells to regulate antibody synthesis: lymphocytes of systemic lupus erythematosus patients are specifically unresponsive to L-canavanine. Clin Immunol Immunopathol 1990; 55(1):97-108.
53. Alcocer-Varela J, Iglesias A. Llorente L, Alarcon-Segovia D. Effects of L-canavanine on T cells may explain the induction of systemic lupus erythematosus by alfalfa. Arthritis Rheum 1985: 28(1):52-57.
54. Mac Lean JA. Unsaponifiable substance from alfalfa for pharmaceutical and cosmetic use. Pharmaceuticals. 1974; 81:339. Ref Type: Abstract.
55. Garrett BJ, Cheeke PR, Miranda CL, Goeger DE, Buhler DR. Consumption of poisonous plants (Senecio jacobaea, Symphytum officinale. Pteridium aquilinum, Hypericum perforatum) by rats: chronic toxicity, mineral metabolism, and hepatic drug-metabolizing enzymes. Toxicol Lett 1982; 10(2-3):183-188.
56. Malinow MR. Experimental models of atherosclerosis regression. Atherosclerosis 1983; 48(2):105-118.